Coya Therapeutics receives FDA fast track designation for ALS treatment
Coya Therapeutics, Inc. (NASDAQ: COYA) announced that the U.S. Food and Drug Administration has granted Fast Track Designation for COYA ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
